Corrections to design, synthesis, and biological evaluation of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives as μ opioid receptor selective antagonists (Journal of Medicinal Chemistry (2009) 52, (1416) DOI 10.1021/jm801272c)

Journal of Medicinal Chemistry

Volumn 52, Issue 24, 2009, Pages 8057-

  Li, Guo ^a   Aschenbach, Lindsey C ^a   Chen, Jianyang ^a   Cassidy, Michael P ^a   Stevens, David L ^a   Gabra, Bichoy H ^a   Selley, Dana E ^a   Dewey, William L ^a   Westkaemper, Richard B ^a   Zhang, Yan ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERRATUM; ERROR;

EID: 73249138744     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9016224     Document Type: Erratum

References (5)

1. Sayre, L. M.; Larson, D. L.; Takemori, A. E.; Portoghese, P. S. Design and synthesis of naltrexone-derived affinity labels with nonequilibrium opioid agonist and antagonist activities. Evidence for the existence of different mu receptor subtypes in different tissues. J. Med. Chem. 1984, 27, 1325-1335.
2. Cashman, J. R.; Macdougall, J. M. Synthesis of Metabolically Stable Analgesics, Pain Medications and Other Agents. PCT Int. Appl. CODEN: PIXXD2. WO 2005117589. A1 20051215. CAN 144:51830. AN 2005:1314244, 2005; 107 pp.
3. Ghirmai, S.; Azar, M. R.; Polgar, W. E.; Berzetei-Gurske, I.; Cashman, J. R. Synthesis and biological evaluation of alpha- and beta-6-amido derivatives of 17-cyclopropylmethyl-3,14beta-dihydroxy-4,5alpha-epoxymorphinan: potential alcohol-cessation agents. J. Med. Chem. 2008, 51, 1913-1924.
4. (a) Yekkirala, A. S.; McCurdy, C. R.; Lunzer, M. M.; Powers, M. D.; Portoghese, P. S. Naphthoyl-beta-naltrexamine (NNTA) Selectively Activates Mu-Kappa Opioid Heterodimers, an Insightful Tool To Study Novel Mechanisms of Analgesia. Presented at the 37th Annual Meeting of the Society for Neuroscience, San Diego, CA, Nov 3-7, 2007; Session 119.
5. (b) Yekkirala, A. S.; Lunzer, M. M.; McCurdy, C. R.; Powers, M. D.; Roerig, S. C.; Portoghese, P. S. NNTA, a Selective Activator of Heterodimeric Mu-Kappa Opioid Receptors Produces No Tolerance or Physical Dependence in Mice. Presented at the 2008 International Narcotics Research Conference, Charleston, SC, July 13-18, 2008.